SG Americas Securities LLC Makes New $1.37 Million Investment in Teleflex Incorporated (NYSE:TFX)

SG Americas Securities LLC bought a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 9,886 shares of the medical technology company's stock, valued at approximately $1,366,000.

Several other institutional investors have also bought and sold shares of TFX. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Teleflex by 4.4% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company's stock worth $1,098,693,000 after acquiring an additional 261,279 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Teleflex by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company's stock valued at $202,161,000 after buying an additional 8,307 shares during the last quarter. Cooke & Bieler LP raised its holdings in shares of Teleflex by 22.1% in the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock worth $191,962,000 after buying an additional 195,150 shares during the period. Invesco Ltd. lifted its stake in shares of Teleflex by 48.1% during the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock worth $190,188,000 after acquiring an additional 347,003 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its holdings in Teleflex by 38.1% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company's stock valued at $105,102,000 after acquiring an additional 162,950 shares during the period. Institutional investors own 95.62% of the company's stock.

Teleflex Stock Down 0.6%

Shares of TFX traded down $0.65 during trading hours on Friday, hitting $117.07. The company had a trading volume of 231,921 shares, compared to its average volume of 867,452. The company has a current ratio of 2.28, a quick ratio of 1.32 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $5.17 billion, a PE ratio of 36.93, a price-to-earnings-growth ratio of 1.84 and a beta of 1.10. Teleflex Incorporated has a one year low of $116.60 and a one year high of $249.90. The company's fifty day moving average price is $125.67 and its two-hundred day moving average price is $150.62.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The firm's revenue was down 5.0% on a year-over-year basis. During the same period in the previous year, the company posted $3.21 earnings per share. As a group, equities analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th were paid a $0.34 dividend. The ex-dividend date was Tuesday, May 20th. This represents a $1.36 annualized dividend and a yield of 1.16%. Teleflex's dividend payout ratio (DPR) is 42.90%.

Wall Street Analysts Forecast Growth

TFX has been the subject of a number of recent analyst reports. Wells Fargo & Company lowered their target price on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a research note on Friday, May 2nd. Mizuho set a $155.00 target price on shares of Teleflex in a research report on Wednesday, April 16th. Bank of America lowered Teleflex from a "neutral" rating to an "underperform" rating and lowered their price target for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. Raymond James Financial cut Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.